
Tazoka 4000mg/500mg Injection
Marketer
Kaps3 Life Sciences
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazoka 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, its dosage and frequency are tailored by your physician based on your condition's severity. Strict adherence to prescribed usage is vital. Potential side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, kidney, or liver issues to your doctor; dosage adjustments or alternative medications may be necessary. Under medical guidance, this injection is generally considered safe during pregnancy and lactation.
Uses of Tazoka 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazoka 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Tazoka 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazoka 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tazoka 4000mg/500mg Injection works:
Tazoka, a 4000mg/500mg injectable formulation, unites piperacillin, a bacterial cell wall synthesis inhibitor, with tazobactam, a beta-lactamase inhibitor. This synergistic blend combats bacterial infections by disrupting bacterial defenses and boosting piperacillin's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tazoka 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectible medication Tazoka, 4000mg/500mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazoka, 4000mg/500mg, presents minimal risk to breastfeeding mothers. Research in humans indicates negligible transfer to breast milk, posing no apparent threat to infants.
DrivingCONSULT YOUR DOCTOR
The effect of Tazoka 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Tazoka 4000mg/500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Tazoka 4000mg/500mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Tazoka 4000mg/500mg Injection in patients with liver conditions appears to pose minimal risk. Preliminary evidence indicates dose modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Tazoka 4000mg/500mg Injection :
Omitting a scheduled dose of Tazoka 4000mg/500mg Injection warrants immediate physician consultation.
Facts to Know About Tazoka 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
